Osman Kibar

$1.70 B

Ranked #1725 in World

About Osman Kibar

Osman Kibar, the Turkish American magnate, and founder of Biosplice, is an innovator in biotechnology with a reported $2.9 billion net worth as of November 2020. With roots in İzmir, Kibar is a graduate of Pomona College and Caltech and holds advanced degrees in biophotonics from UC San Diego. His career includes the launch of Genoptix, acquired by Novartis for $476 million, and the creation of Biosplice, focusing on disease treatments. A family man and thrifty spender, Kibar balances business with hobbies like playing go and poker.

Born

April 01, 1971

Age

55 years

Source Of Wealth

Biotech

Industries

Healthcare

Citizenship

United States

Residence

La Jolla, California

Education

Bachelor of Arts/Science, California Institute of Technology; Bachelor of Arts/Science, Pomona College; Master of Science, University of California, San Diego; Ph.D, University of California, San Diego

Osman Kibar, a Turkish American billionaire and founder of the biotechnology firm Biosplice, was born in 1971 in İzmir, Turkey. He is the grandson of Osman Kibar, who served as the mayor of İzmir from 1964 to 1973. Kibar attended İzmir Gazipaşa Primary School and Robert College before enrolling in a 3-2 program at Pomona College (economics) and Caltech (electrical engineering). He later pursued a master's degree and doctorate in biophotonics at UC San Diego.

Osman Kibar: Family

Osman Kibar is married and has four children. Despite his immense wealth, he is known for his frugal spending habits and enjoys free activities such as reading, playing go, and going to the movies. Interestingly, Kibar is also a skilled poker player and won his first tournament in 2006.

Osman Kibar: Career Highlights

While completing his doctorate, Kibar invented a groundbreaking cancer diagnosis system. This invention led to the establishment of Genoptix, a company that went public and was eventually acquired by Novartis in 2011 for an impressive $476 million. After this successful venture, Kibar worked for the hedge fund sponsor Pequot Capital in New York City.

In 2011, Kibar founded Wintherix (later renamed Samumed and Biosplice) in San Diego with a $3.5 million investment from Cevdet Samikoğlu. The company, which has attracted investments from prominent figures like Ali Sabancı and Ergun Özen, focuses on researching cures for various diseases and conditions.

Osman Kibar: Companies

Osman Kibar has been involved with several notable companies throughout his career. He founded Genoptix, a successful biotechnology company acquired by Novartis. Kibar also worked for Pequot Capital, a hedge fund sponsor based in New York City. His most significant venture, however, is Biosplice (formerly known as Wintherix and Samumed), a San Diego-based company dedicated to researching cures for various diseases.

Osman Kibar: Major Achievements

Kibar's major achievements include inventing a cancer diagnosis system, founding Genoptix and Biosplice, and successfully leading these companies.

His contributions to the field of biotechnology have been significant, and he continues to drive innovation in the industry.

Osman Kibar: Awards & Achievements

Osman Kibar has received numerous awards and accolades for his contributions to science and business. He was ranked eighth on Forbes Turkey's 2017 list of 100 richest Turks, a testament to his remarkable success.

Osman Kibar: Personal Life & Legacy

Kibar is known for his humble and frugal lifestyle despite his immense wealth. He enjoys spending time with his family and engaging in simple pleasures like reading, playing go, and going to the movies. Kibar's legacy lies in his groundbreaking work in biotechnology and his commitment to finding cures for various diseases.

Osman Kibar: Trivia

Osman Kibar is a skilled poker player and won his first tournament in 2006. He is also an avid reader and enjoys playing go, a strategic board game.

Wealth History

Timeline

1971

Osman Kibar is born in İzmir, Turkey.

1964-1973

Osman Kibar's grandfather serves as mayor of İzmir.

N/A

Osman Kibar attends İzmir Gazipaşa Primary School and Robert College.

N/A

Osman Kibar completes a 3-2 program at Pomona College (economics) and Caltech (electrical engineering).

N/A

Osman Kibar earns a master's degree and doctorate in biophotonics at UC San Diego.

N/A

While completing his doctorate, Osman Kibar invents a cancer diagnosis system.

N/A

Osman Kibar founds Genoptix, which later goes public and is acquired by Novartis in 2011 for $476 million.

N/A

Osman Kibar works for hedge fund sponsor Pequot Capital in New York City.

2011

Osman Kibar establishes Wintherix (later renamed Samumed and Biosplice) in San Diego with a $3.5 million investment from Cevdet Samikoğlu.

N/A

Ali Sabancı and Ergun Özen join as investors in Osman Kibar's company.

N/A

Osman Kibar's company focuses on researching cures for various diseases and conditions.

N/A

Osman Kibar gets married and has four children.

N/A

Despite his wealth, Osman Kibar lives frugally and enjoys free activities such as reading, playing go, and going to the movies.

2006

Osman Kibar enters and wins his first poker tournament.

November 2020

Osman Kibar's net worth is estimated at $2.9 billion.

2017

Osman Kibar ranks eighth on Forbes Turkey's list of 100 richest Turks.

Osman Kibar : FAQs

What is Osman Kibar's net worth?

As of 2023, Osman Kibar's net worth was $1.70 billion.

What are Osman Kibar's main sources of wealth?

Osman Kibar's main source of income comes from Biotech.

In which industry does Osman Kibar primarily operate?

Osman Kibar is primarily involved in the Healthcare industry.

What is Osman Kibar educational background?

Osman Kibar holds a Bachelor of Arts/Science from California Institute of Technology, a Bachelor of Arts/Science from Pomona College, a Master of Science from the University of California from San Diego and a Ph.D from the University of California from San Diego.

How old is Osman Kibar?

Osman Kibar is 55 years old.

How many children does Osman Kibar have?

Osman Kibar has 4 children.

Who is Osman Kibar, the founder of biotechnology firm Biosplice?

Osman Kibar is a Turkish American billionaire and the founder of Biosplice, a prominent biotechnology firm.

How did Osman Kibar begin his career, and what are some of his achievements?

Osman Kibar invented a cancer diagnosis system while finishing his doctorate. He founded Genoptix, which was later acquired by Novartis for $476 million. After working for Pequot Capital in New York, he established Biosplice in San Diego, focused on researching cures for various diseases.

Can you share details about Osman Kibar's personal life?

Osman Kibar is married with four children. He is known for being frugal with his money and enjoys cost-free hobbies like reading, playing go, and watching movies. He is also a successful poker player, having won the first tournament he entered in 2006.